Physician profile
Edwin C Newman
NPI 1083692131
$2,836.79
in general payments reported to CMS, 2019-2025
32 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2020: $354 · 2021: $397 · 2022: $181 · 2023: $107 · 2024: $1,060 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $959 · Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $959.32 |
| Food and Beverage | $364.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tricoast Surgical Solutions LLC | $531.97 | 2024 | |
| Arthrex, INC. | $451.35 | 2024 | |
| Horizon Therapeutics Plc | $419.69 | 2019-2022 | |
| Depuy Synthes Sales INC. | $314.25 | 2019-2025 | Attune |
| Stryker Corporation | $191.83 | 2019-2023 | T2 |
| Smith+Nephew, INC. | $114.50 | 2019-2024 | Stravix, Bone Anchors With Arthroscopic Delivery System, Grafix Pl |
| Fidia Pharma USA INC. | $98.63 | 2019 | |
| Amgen INC. | $82.81 | 2019-2022 | |
| Orthofix Medical, INC. | $66.55 | 2020 | |
| Ermi LLC | $60.80 | 2019-2021 | |
| Radius Health, INC. | $41.08 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $33.30 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $33.15 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $31.74 | 2019-2020 | |
| Davol INC. | $30.98 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Precision Medical Products INC. | $29.99 | 2021-2022 | |
| Ethicon US, LLC | $28.25 | 2025 | Vistaseal |
| Medtronic USA, INC. | $26.71 | 2019 | |
| Zimmer Biomet Holdings, INC. | $25.37 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.74 | 2019 | |
| Kinex Medical Company LLC | $21.34 | 2019 | |
| Pacira Therapeutics, INC. | $21.25 | 2021 | |
| Djo, LLC | $20.35 | 2019 | |
| Eyepoint US, INC. | $19.96 | 2021 | |
| Acera Surgical, INC. | $19.10 | 2022 | |
| Medacta USA, INC. | $17.82 | 2019 | |
| Biodelivery Sciences International, INC. | $17.39 | 2021 | |
| Bioventus LLC | $14.43 | 2024 | Durolane |
| Apria Healthcare LLC | $13.71 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $12.19 | 2019 | |
| Convatec INC. | $11.31 | 2020 | |
| Daiichi Sankyo INC. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.